NEXOPAMIL
UNII ECA0E1PO91

Substance Identification & Data

This profile provides standardized clinical and technical data for Nexopamil, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ECA0E1PO91.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 136033-49-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ECA0E1PO91

CAS Registry Number

136033-49-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NEXOPAMIL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C24H40N2O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

SKDZEFVVFACNLS-DEOSSOPVSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C66239

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

65984

Unique identification number in the NCBI database of chemical substances.

INN ID

6935

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

COc1c(cc([C@@](CCCN(CCCCCC)C)(C#N)C(C)C)cc1OC)OC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nexopamil. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.